The IPO market underperformed in 2024 ... inspired by Japan’s regulatory framework, as a model for U.S. regulators. Zhang noted. “A country like Japan offers a good example of how regulators can ...

The introduction of AI Thinking offers a critical shift from technology-driven AI development to purpose-driven AI ...

The primary market to be back in action with nine new initial public offerings (IPO) set to open for subscription next week. Apart from new public issues, the market will also witness six new ...

Stallion India IPO allotment has been finalied and the shares of Stallion India Fluorochemicals are likely to be listed on January 23.(Image: Company Website) Stallion India Fluorochemicals IPO ...

When we introduced the Nasdaq IPO Pulse a year ago, we said it suggested that U.S. “IPO activity… should remain in an uptrend” as we headed into 2024. Then, when we introduced the Nasdaq ...

The BDC segment is my favorite area to invest for high and durable income. In fact, my highest-conviction investment is a BDC ...

Beyond using AI to draft IPO prospectuses to court potential clients ... and cutting down on redundancies in the equity-research example would be "a massive process change." ...

Denta Water and Infra IPO got fully subscribed within minutes of opening for bidding on January 22 in the primary market. Founded in 2016, Denta Water and Infra Solutions Ltd has emerged as one of ...

[an IPO is] the plan.” Mistral, which Mensch launched in 2023 alongside former researchers from Google’s DeepMind and Meta, is often described as Europe’s answer to U.S. incumbents like OpenAI.

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

An earlier version of this story misspelled the name of Smithfield Foods Inc. in its headline. Smithfield Foods Inc. is offering Wall Street a seat at the table for potential growth in its ...

Odyssey Therapeutics and Sionna Therapeutics have filed IPO paperwork, swelling the pack of startups that will provide an early look at how receptive public investors could be to biotech listings ...